April 19: COA Lauds the Introduction of the Prescription Drug Price Transparency Act
Representative Doug Collins (R, Georgia) has proposed a bill that would increase the transparency of payment methodologies to pharmacies. The Prescription Drug Price Transparency Act (H.R. 1316) was introduced in the House of Representatives on March 2, with the intent of requiring pharmacy benefit managers (PBMs) to disclose their generic drug pricing information.
Read the full article on Targeted Oncology here.
April 19: COA Lauds the Introduction of the Prescription Drug Price Transparency Act
Representative Doug Collins (R, Georgia) has proposed a bill that would increase the transparency of payment methodologies to pharmacies. The Prescription Drug Price Transparency Act (H.R. 1316) was introduced in the House of Representatives on March 2, with the intent of requiring pharmacy benefit managers (PBMs) to disclose their generic drug pricing information.
Read the full article on Targeted Oncology here.